Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
Allogene Therapeutics, Inc. SOUTH SAN FRANCISCO, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the developmen...